[1] 陈超,郭代红,刘皈阳,等.医疗机构药品不良反应监测的优化实践[J].中国药物警戒,2010,7(3):164-168. [2] ChaoChen, Dai-HongGuo, XiutangCao, et al. Risk factors for thrombocytopenia in adultchinese patients receiving linezolid therapy[J].CURR THER RES CLIN E,2012,73(6):195-206. [3] 陈超,郭代红,曹秀堂,等.住院患者使用利奈唑胺致相关性血小板减少症的危险因素分析[J].中国药物警戒,2012,9(2):71-76. [4]郭代红,陈超,李馨,等.6所医院 414例利奈唑胺相关性血小板减少集中监测研究[J].药物流行病学杂志,2013,22(3):109-113. [5] 陈超,郭代红,刘皈阳,等. 解放军药品不良反应网络填报管理系统的研发[J].中国药物应用与监测,2008,5(4):20-24. [6] Alan J Forster,Alison Jennings,Claire Chow, et al. A systematic review to evaluate the accuracy of electronic adverse drug event detection[J]. J Am Med Inform Assoc,2012,19:31-38. [7] 薛万国.新阶段HIS 的功能定位与基本特征[J].医疗卫生装备,2010,31(2):8-10. [8] 俞朝辉,王如华.合理用药监测软件在HIS 中的应用[J].中国高等医学教育,2007(4):95-96. [9] 徐帆,朱恺,杨伶俐.利用合理用药软件系统对医院用药情况进行评价[J].西南国防医药,2004,14(3):296-299. [10] Garg A X, Adhikari N K, McDonald H,et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes[J]. JAMA, 2005,293(10):1223-1238. [11] KhajoueiR, Wierenga P C, Hasman A, et al. Clinicians satisfaction with CP0E ease of use and effect on clinicians' workflow, efficiency and medication safety[J]. Int J Med Inform, 2011, 80(5):297-309. [12] 郭代红,杜晓曦,陈珲,等. PASS 监测用药风险警示的评估及成因分析[J].中国药物警戒,2010,7(4):217-220. [13] Kilbridge P M,Classen D C. Automated surveillance for adverse events in hospitalized patients:back to the future[J].Qual Saf Health Care,2006,15:148-149. [14] AndreaLLong,MonicaMHorvath, Heidi Cozart. Tailoring adverse drug event surveillance to the paediatric inpatient[J].Qual Saf Health Care , 2010,19:1-5. |